TY - JOUR
KW - Humans
KW - United Kingdom/epidemiology
KW - Female
KW - Middle Aged
KW - Aged
KW - Male
KW - Incidence
KW - Adult
KW - *Breast Neoplasms/epidemiology/mortality
KW - Prevalence
KW - Aged, 80 and over
KW - Adolescent
KW - Young Adult
KW - Breast Neoplasms, Male/epidemiology/mortality
KW - Survival Rate
AU - N. Barclay
AU - E. Burn
AU - A. Delmestri
AU - T. Duarte-Salles
AU - A. Golozar
AU - W . Y. Man
AU - E. Tan
AU - I. Tietzova
AU - D. Prieto-Alhambra
AU - D. Newby
AD - Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK.
Fundació Institut Universitari Per a La Recerca a L'Atenció Primària de Salut Jordi Gol I Gurina (IDIAPJGol), Barcelona, Spain.
Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Odysseus Data Service, Cambridge, MA, USA.
OHDSI Center at the Roux Institute, Northeastern University, Boston, MA, USA.
First Department of Tuberculosis and Respiratory Diseases, First Faculty of Medicine, Charles University, Katerinska 1660/32, 121 08, Prague, Czech Republic.
Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, OX3 7LD, UK. daniel.prietoalhambra@ndorms.ox.ac.uk.
Department of Medical Informatics, Erasmus University Medical Centre, Rotterdam, The Netherlands. daniel.prietoalhambra@ndorms.ox.ac.uk.
AN - 39153995
BT - Sci Rep
C2 - PMC11330450 from the European Medicines Agency from the Innovative Medicines Initiative from Amgen Chiesi and from UCB Biopharma; and consultancy or speaker fees (paid to his department) from Astellas Amgen Astra Zeneca and UCB Biopharma. NLB is Director of Sleep Universal Limited (though this work is in no way connected to the present manuscript). All other authors declare no conflicts of interest.
DO - 10.1038/s41598-024-69006-1
DP - NLM
ET - 2024/08/18
LA - eng
M1 - 1
N1 - 2045-2322
Barclay, Nicola L
Burn, Edward
Delmestri, Antonella
Duarte-Salles, Talita
Golozar, Asieh
Man, Wai Yi
Tan, Eng Hooi
Tietzova, Ilona
OPTIMA Consortium
Prieto-Alhambra, Daniel
Newby, Danielle
806968/Innovative Medicines Initiative 2 (IMI2) Joint Undertaking/
101034347/optima/
Journal Article
England
Sci Rep. 2024 Aug 17;14(1):19069. doi: 10.1038/s41598-024-69006-1.
PY - 2024
SN - 2045-2322
EP - 19069
T2 - Sci Rep
TI - Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021
VL - 14
ER -